Eli Lilly & Co. (LLY)
$34.50
0.07 (+0.20%)
| CAPS Rating |
|
|---|---|
| Open | $34.39 |
| Previous Close | $34.43 |
| Daily Range | $34.16 - $34.53 |
| 52-Week Range | $27.21 - $40.78 |
| Market Cap | $39.64B |
| P/E Ratio | 17.77 |
| Dividend (Yield) | 1.96 (5.70%) |
| Volume | 9,027,242 |
| Average Daily Volume | 7,220,000 |
LLY
VS S&P 500 (SPY)
How do you think LLY will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
LLY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
LLY News and Commentary
- Eye on Insiders: Johnson & Johnson – The Motley Fool
- Will These Investments Beat Immediate Annuities? – The Motley Fool
- Congress Approves $500 Billion for Monument to Human Folly – Blog at The Motley Fool
- An Ode to Schering-Plough – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- CNBC on Eli Lilly & Company – Ockham-RazorWire
- UPDATE 1-US FDA issues alert on kidney problems with Byetta – Reuters
- Eli Lilly: Warming Up or Cooling Off? – The Motley Fool
- Shrugging Off the Side Effects – The Motley Fool
- It's Not As Frightening As It First Appears – The Motley Fool
- Of One-Time Gains and Pipelines – The Motley Fool
- World's Scariest Stocks: Pfizer – The Motley Fool
- GE, Verizon and Wal-Mart: Scary stocks – CNN Money
- The Waters Aren't Flowing. Yet. – The Motley Fool
- Psst … Here's How Your Company Will Do – The Motley Fool
- Eli Lilly stock: Hurt by patent loss – CNN Money
- Dream Stocks for Contrarian Investors – The Motley Fool
- Stock Smackdown: Cramer vs. CAPS – The Motley Fool
- I Don't Need No Massive Merger – The Motley Fool
- Merck-Schering Doesn't Look So Good – The Motley Fool
RSS Headlines
Fool UK
